Member Info for whimax

Nice shake down lol. BTFDs

Good post mate. I agree with the sentiment. I also still feel some embarrassment for recommending Chariot, and ultimately costing family and friend money.

One thing I would say tho, is Chariot of old was basically a wildcat drill company and GS, CS et all knew that. They knew the risks, just like the rest of us, so if they got burned (like us minions) it makes a change lol.
They have no real right to hold a grudge against Chariot because they were well looked after during the placings, especially the one at 14p when the share price was at 22p the night before. If they can’t mitigate risk with discounts like that, they shouldn’t be playing the game.

Having said the above, I do agree that some of the less researched will be wary.

GL

Yes, I agree Chablard. I did caveat my post a little tho, by asking what %age (after tax) £5k/£10k was as part of their annual NFX salary.
I honestly don’t know what these guys take home pay is on a monthly basis, so it’s hard to judge how significant that amount of money is to each of them. I suspect they are not currently on big bucks tho.

Also, there were a few digs at the BoD yesterday for the size if their involvement in the placing (£25,000 between them). Whilst I agree to a certain extend that this is small change, if the BoD suspected that Oxilio would walk, why wouldn’t they just wait till after 23rd March and buy shares at that point. It would show a bit of solidarity and confidence in what was left of the business, and also (most probably) give them more shares at a price lower than 2p.
Finally, although £5k each (£10k for Anne) isn’t much, what %age of their annual NFX salary is that after tax? Anyone know?

Hi Legalwolf.

The short answer, from my perspective anyway, is that the Chariot of today does not even remotely resemble the Chariot of even 2 years ago. Yes, the legacy plays from yesteryear are still on the books and may (hopefully) progress and influence the share price in a positive way, but assuming Morocco plays out as expected, I’d go as far as to say they won’t be needed and will represent a mere bonus.
I think the last time the SP was above 20p (for example) was in the lead up to, and in anticipation of, the last drill. Before the drill happened, and before the run up to the drill was complete, there was a placing at 35% discount (from memory). The share price tanked to placing price, never recovered then hit 5p on a duster shortly after, before dropping to 2p. Imo the only relevance a chart can have is therefore to give an indication of volumes around those areas and possibly (at real stretch imo) some resistance and support points. I don’t see how a chart can look historically at that scenario, with what is happening now (with such a long time in between) and make a comparison.

Chartists, I’m sure, will have a different view, but FWIW, thats my tuppence worth lol.

Last one from me to you.

Here is a challenge for you? Can you copy and paste a single one your posts from today that has any reference to this mornings RNS or anything even remotely relevant to NFX? I have never seen anyone post so much, say so little, in all my time on these BB’s.

Are you invested in this share, just as a matter of interest.

If they’re not, then they don’t want to be imo.

Also, Anne said on several occasions that the placing was oversubscribed. Is she saying that NFX could have raised more than they did, but decided not to (because they don’t need it), OR they were only looking to raise say £1m but ended up with more?

Anne’s comments to Proactive Investor are interesting imo. I do wonder if Oxilio have been playing hardball with regards negotiations, knowing (as we shareholders do) that the bank balance was/is running low. Is the timing of this placing significant? They have till 23rd March to decide, but NFX’s funding (or lack of it) is no longer a negotiating tool (well not for Oxilio anyway).

“ On 23 September last year, Nuformix granted Oxilio, a private pharmaceutical development company, an option to licence NXP001 globally for repurposing in oncology. Under the agreement, Oxilio has an exclusive option period that ends on March 23. Should Oxilio exercise the option and a global licence deal be negotiated, Nuformix will licence its patent estate and know-how on NXP001 in return for an upfront payment, development milestones and a royalty on net sales, capped at £2mln per annum. However, if the option is not exercised, Nuformix will pursue additional business development opportunities for NXP001 in oncology with the potential to generate value from this asset.”

And AGAIN later

“ In addition, we await the outcome of Oxilio’s option to license one of our other assets, NXP001. However, as mentioned, should Oxilio not exercise the option to license NXP001 in oncology some of the proceeds of the Placing would be used to pursue additional business development opportunities for NXP001 in oncology.”

I’m impressed they got the placing away at just a 15% discount to be honest. As annoying and frustrating as it is, at least that issue can now be put to bed.

Agree on the point re Anne Goup. I think she’s been somewhat hoodwinked into this position.

No point selling now. At least now we know what the plan is and that the base is circa 2p.

Apologies, that should have said 18th February.

When I emailed IG on 18th March (just before the list came out) and asked why NfX was closing only I was told this.

“The two stocks mentioned are on closings-only because our broker's margin is too high. It is not feasible for us to offer them on leverage.”

Thanks Soup. Is that not a bit risky on their part tho? I don’t know, I’m just musing.

I had, what in reality, were 2 small positions each of £1000 p/p (so in effect 200,000 shares) but at 3.5p and deposit requirement of only 25% that’s only £1750 I needed to find. If news had dropped and this had shot to 15p thats £23k profit they are paying to me alone. Is it worth the risk to them, NOT to hold shares to hedge that when it’s extrapolated out across their platform?
I guess the number they hold is limited, and that’s borne out by the fact that latterly they have gone to closing only more and more frequently, but in my experience, bookies seldom leave themselves over exposed.

Anyone else think this drop is still partly IG related?

What I mean is, existing Spread Bets were/are able to stay open until the end of this month on NFX, albeit they now require 100% margin. It is possible that some will have closed out into last weeks news (which won’t have helped momentum for starters), but as further bets (and CFD’s) have to close as the month goes on, presumably IG will need to hold less and less shares to hedge against those bets, so will just sell them back into the market.
I had 4 stocks affected and still have 1 which now has 100% margin. 3 of those stocks have released news in the last week which has either been pretty much ignored, or has had a far more muted reaction than I would have expected.

Just a thought.

Nice work by LSE Admin. :-)

Can I suggest that everyone just reports this persons posts rather than replying to it.

The more people that report these posts, the quicker they and it will be removed from LSE.

For over 5 minutes lol.

Anyone who doesn’t realise by now that Shorters hardly ever lose, is off their head lol. There’s a reason for that.

No reason for this other than Shorts closing imo. Shorts NOW know where BTC is going and that their gamble has backfired. Big push down on all Crypto Miners to let them out.
Monday will be very different imo.

GL

Yes, level pegging now Oldapache, for the first time in a long time. Hopefully the basis for a move back to sensible levels.

GL all